-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
STING agonist-1
Category | Virus Protease |
CAS | 702662-50-8 |
Description | STING agonist-1 (G10) is a novel human-specific STING agonist (IC90 = 24.57 μM), exhibits no direct binding affinity for STING |
Product Information
Synonyms | G10; G10; G-10; G 10; STING agonist G10;4-[(2-Chloro-6-fluorophenyl)methyl]-N-(2-furanylmethyl)-3,4-dihydro-3-oxo-2H-1,4-benzothiazine-6-carboxamide; |
IUPAC Name | 4-[(2-chloro-6-fluorophenyl)methyl]-N-(furan-2-ylmethyl)-3-oxo-1,4-benzothiazine-6-carboxamide |
Molecular Weight | 430.88 |
Molecular Formula | C21H16ClFN2O3S |
Canonical SMILES | c1cc(c(c(c1)Cl)CN2c3cc(ccc3SCC2=O)C(=O)NCc4ccco4)F |
InChI | 1S/C21H16ClFN2O3S/c22-16-4-1-5-17(23)15(16)11-25-18-9-13(6-7-19(18)29-12-20(25)26)21(27)24-10-14-3-2-8-28-14/h1-9H,10-12H2,(H,24,27) |
InChIKey | NAGKYJATVFXZKN-UHFFFAOYSA-N |
Purity | ≥98% |
Solubility | Soluble in DMSO |
Appearance | Off White solid |
Application | Activator of STING-dependent signaling; exhibits no direct binding affinity for STING |
Shelf Life | As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly |
Storage | Store at -20 °C |
Complexity | 613 |
Exact Mass | 430.0554194 |
In Vitro | G10 induces IFN/IRF3- but not NF-κB-dependent transcription in human fibroblasts. G10 is an indirect activator of human STING-dependent phenotypes. G10-mediated IRF3 activation and anti-Alphaviral activity occur independently of IPS-1/MAVS-dependent signaling. STING is required for G10-mediated IRF3 activation, gene expression, and anti-Alphaviral activity. G10 induces STING-dependent synthesis and secretion of bioactive interferon. G10 induces innate antiviral mRNA expression in primary human cells. |
Target | IC90: 24.57 μM (VEEV) |
XLogP3-AA | 3.7 |